secwatch / observer
8-K filed January 24, 2023, 6:59 PM ET ticker LMT CIK 0000936468
earnings confidence medium sentiment neutral materiality 0.75

Lockheed Martin Q4 EPS $7.40 ($7.79 adj.); backlog $150B; FY23 outlook issued

LOCKHEED MARTIN CORP

2022-FY EPS reported $21.66 revenue$65,984,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

LOCKHEED MARTIN CORP reported the year ended December 31, 2022 results: revenue $66.0 billion, net income $5.7 billion, or $21.66 per share, EPS $21.66 per share. Guidance initiated.

Period
the year ended December 31, 2022
Revenue
$66.0 billion
Net income
$5.7 billion, or $21.66 per share
EPS
$21.66 per share
Guidance
initiated
Result
reported results
Exact text from the filing
Net sales in 2022 were $66.0 billion, compared to $67.0 billion in 2021. Net earnings in 2022 were $5.7 billion, or $21.66 per share
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 1.0

LOCKHEED MARTIN CORP reported the quarter ended December 31, 2022 results: revenue $19.0 billion, net income Net earnings of $1.9 billion, or $7.40 per share, EPS $7.40 per share. Guidance initiated.

Period
the quarter ended December 31, 2022
Revenue
$19.0 billion
Net income
Net earnings of $1.9 billion, or $7.40 per share
EPS
$7.40 per share
Guidance
initiated
Result
reported results
Exact text from the filing
Lockheed Martin Corporation [NYSE: LMT] today reported fourth quarter 2022 net sales of $19.0 billion, compared to $17.7 billion in the fourth quarter of 2021. Net earnings in the fourth quarter of 2022 were $1.9 billion, or $7.40 per share
View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

LOCKHEED MARTIN CORP filing history →

Source: SEC EDGAR
accession 0000936468-23-000004
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.